Developer docs
API playgroundTry for free, no card

Search company profiles

Integral Diagnostics

Full company profile

uuid00073n2

Namestring
Integral Diagnostics
Legal namestring
Integral Diagnostics Limited
Company typeenum
Public
Founded yearstring
-
Descriptiontext

Integral Diagnostics Limited (ASX: IDX) is an Australian-headquartered, publicly listed diagnostic imaging services provider operating a network of 155 clinics across six Australian states and New Zealand, supported by 350+ radiologists and 3,000+ employees following the December 2024 merger with Capitol Health. The company delivers a full range of medical imaging modalities — X-ray, CT (including dual-source CT), MRI, ultrasound, mammography, PET-CT, nuclear medicine, bone densitometry, dental imaging and interventional procedures — through regional brands such as Capital Radiology, Apex Radiology, Lake Imaging, South Coast Radiology, Radiology Tasmania, and Astra Radiology in New Zealand. Its technology stack combines PACS/RIS for image management with the Aidoc aiOS AI platform (deployed across 185 facilities, processing 600,000+ cases since 2019) for automated critical-pathology flagging, the IDXt home-based teleradiology platform (124 radiologists) for after-hours and overflow reporting, and a Deloitte-led centralized technology modernization initiative.

The business model is primarily fee-for-service diagnostic imaging reimbursed through Australia's Medicare Benefits Schedule, New Zealand's Accident Compensation Corporation, private health insurers, and government screening programs such as the National Lung Cancer Screening Program (NLCSP) launched July 2025. Revenue streams include patient imaging services billed through referrals (the dominant channel), hospital and enterprise contracts for on-site radiology and teleradiology reporting (via IDXt), and emerging consumer-paid services such as Astra's Auckland whole-body wellness scanning. Distribution combines a physical owned-clinic network with B2B hospital contracts and government-program participation (Chest Scan Australia covers 85 NLCSP-eligible sites). Customers are long-tail referred patients and a meaningful but diversified base of public and private hospitals.

In H1 FY2026, the company reported revenue of AUD 393.5 million (up 55.6% following the Capitol merger), operating EBITDA of AUD 81.1 million (up 75.6%) at a 20.6% margin (+230 bps), and net income of AUD 14.0 million, with FY2026 EBITDA margin guidance of 21% and 7.5% organic growth. Net debt-to-EBITDA improved to 2.5x. The company is targeting the second-largest diagnostic imaging position in Australia and is investing in regional expansion (new clinics in Tasmania, Victoria and South Australia), AI capability scaling with Aidoc, and a wholesale technology modernization with Deloitte.

Short descriptiontext

Integral Diagnostics (ASX: IDX) operates 155 diagnostic imaging clinics across Australia and New Zealand, employing 350+ radiologists to deliver X-ray, CT, MRI, ultrasound, mammography, PET-CT and interventional imaging services to referred patients, hospitals and screening programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersNorth Melbourne, Australia
HQ citystring
North Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic imaging services, medical imaging, teleradiology reporting, radiology clinics, healthcare imaging
Industry3 codes
1Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
CodeHLAFAKAAPrimaryYes
2Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
CodeHLAFAKABPrimaryNo
3Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)
CodeHLAKABAEPrimaryNo
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • All Other Outpatient Care Centers621498
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Diagnostic Imaging Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Diagnostic Imaging Services
TypeTransaction Fee
Description

Fee-for-service medical imaging revenue from X-ray, CT, MRI, ultrasound, mammography, PET-CT, and other imaging modalities. Services are billed through Medicare rebates in Australia and private health insurance, with some services covered under government screening programs like the National Lung Cancer Screening Program.

in.investing.com
2Hospital Contracts
TypeManaged Services
Description

Contracts with public and private hospitals for radiology services, including after-hours teleradiology through the IDXt platform.

integraldiagnostics.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Medicare-funded diagnostic imaging
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Medicare rebates cover eligible diagnostic imaging services under the Medicare Benefits Schedule (MBS). Patients may have out-of-pocket costs depending on coverage and referral type.

integraldiagnostics.com.au
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Chest Scan Australia
Description

Brand developed to support the National Lung Cancer Screening Program, providing easy access to lung cancer screening throughout Australia with 85 eligible sites

integraldiagnostics.com.au
+1 more record
Core offering1 text field

Integral Diagnostics operates a network of 155 diagnostic imaging clinics across Australia and New Zealand, providing X-ray, CT, MRI, ultrasound, mammography, PET-CT, nuclear medicine and interventional radiology services. The company also runs the IDXt teleradiology platform delivering overflow and after-hours reporting to hospitals and community practices, and has launched Chest Scan Australia to support the National Lung Cancer Screening Program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 600,000+ cases processed by Aidoc AI platform since 2019
+3 more records
Product overview1 text field

Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, operating as a unified platform of 20+ regional brands and 155 clinics. The portfolio includes core teleradiology platform IDXt, regional practices (Apex Radiology, Capital Radiology, Lake Imaging, Radiology Tasmania, South Coast Radiology, Sunshine Coast Radiology), subspecialty centers (Imaging at Olympic Park for musculoskeletal, Astra Radiology for wellness imaging in NZ), and Chest Scan Australia for lung cancer screening. Services span X-ray, CT, MRI, ultrasound, mammography, PET-CT, nuclear medicine, bone densitometry, cardiac imaging, and interventional procedures. The company employs 350+ radiologists across 3,000+ employees, augmented by Aidoc AI technology for automated pathology flagging.

Product and service6 records
1Diagnostic Imaging Services
CategoryDiagnostic Imaging
Description

Core imaging examinations including X-ray, CT, MRI, ultrasound, mammography, PET-CT, nuclear medicine, interventional radiology, dental imaging, and bone densitometry (DEXA) provided to patients referred by GPs or specialists across the IDX clinic network.

2IDXt Teleradiology
CategoryTeleradiology Services
Description

Specialist overflow and after-hours teleradiology reporting service for hospitals and community practices, with 124 radiologists (33% growth) providing remote radiology reporting capacity.

3Chest Scan Australia
CategoryLung Cancer Screening
Description

Brand developed to support the National Lung Cancer Screening Program (NLCSP), providing low-dose CT chest scans and expert subspecialty chest reporting at 85 eligible sites across Australia. Medicare introduced two new lung screening items as part of the NLCSP on 1 July 2025.

4Astra Radiology Wellness Imaging
CategoryWellness and Preventive Imaging
Description

First-of-its-kind whole-body wellness scanning service in Auckland, New Zealand, in partnership with Well For Life, Autonomy Health, and Novator. Services include Multi-region MRI, CT Coronary Artery and Calcium Score, Lung CT, Prostate MRI, and DEXA Bone Density Scanning for early intervention and preventive healthcare.

5Cardiac Imaging Services
CategoryCardiac Imaging
Description

Range of cardiac imaging services including CT Calcium Score screening, CT Coronary Arteries, Echocardiography, and Myocardial Perfusion (MIBI) scans to assist GP or Specialist in diagnosis.

6Dual Source CT Scanning
CategoryAdvanced CT Imaging
Description

Premium cardiac CT imaging and advanced imaging applications using Siemens SOMATOM dual source CT technology, providing superior image quality, fast speed, and lowest radiation dose for patients, with the ability to perform cardiac CT at any heart rate.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-14
Description

Astra Radiology partnered with Well For Life, a wellness provider in Auckland, New Zealand, to deliver whole-body wellness scanning services as part of a holistic preventive healthcare offering.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-14
Description

Astra Radiology partnered with Autonomy Health, a wellness provider in Auckland, New Zealand, to deliver whole-body wellness scanning services as part of a holistic preventive healthcare offering.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-14
Description

Astra Radiology partnered with Novator as a wellness provider in Auckland, New Zealand, to deliver whole-body wellness scanning services as part of a holistic preventive healthcare offering.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-04-17
Description

Technology modernization initiative implementing a centralized system to improve data integration, automation, and operational flexibility. The initiative aims to address issues of data silos and fragmented systems, enabling better data-driven decision-making.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-10-16
Description

Expanded AI partnership with Aidoc, a global pioneer in clinical AI solutions. Aidoc's award-winning aiOS platform automatically flags critical pathologies including brain aneurysms, pulmonary embolisms, stroke, and brain bleeds. Since 2019, Aidoc has processed over 600,000 cases across 185 facilities for IDX. The partnership includes trialing new chest CT AI algorithms for the National Lung Cancer Screening Program.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Australia's largest private hospital operator, with diagnostic imaging embedded in many of its facilities and through Ramsay Connect. Overlaps with IDX on hospital imaging contracts and radiology services within hospitals.

TypeBroad incumbent
Description

Sonic Healthcare is a global diagnostics powerhouse primarily focused on pathology but also operating imaging services through brands such as SKG Radiology and Queensland X-Ray. It competes with IDX on hospital and specialist contracts and offers broader diagnostics portfolio.

TypeOthers
Description

Clinical AI platform partner of IDX that automatically flags critical pathologies in medical images. While not a direct competitor, Aidoc is a strategic technology enabler for IDX's AI-powered radiology workflow and a key ecosystem partner.

TypeDirect peer
Description

Largest diagnostic imaging provider in Australia, operating a network of clinics offering X-ray, CT, MRI, ultrasound, nuclear medicine, and interventional radiology. Directly competes with IDX in metropolitan and regional markets across Australia on referral channels, hospital contracts, and radiologist talent.

TypeEmerging player
Description

New Zealand healthcare provider offering diagnostic imaging alongside other specialist services. Operates in NZ where IDX has presence through Astra, Trinity MRI and SRG, representing a smaller-scale regional competitor.

TypeDirect peer
Description

Queensland X-Ray operates a network of diagnostic imaging clinics across Queensland, offering a comprehensive range of imaging modalities. Direct regional competitor to IDX's Imaging Queensland, Sunshine Coast Radiology and Central Queensland Radiology brands in the Queensland market.

TypeDirect peer
Description

New Zealand-based diagnostic imaging provider with multiple Auckland locations offering MRI, CT, ultrasound, X-ray and women's imaging services. Directly competes with IDX's Auckland-based Astra Radiology in the New Zealand market.

TypeDirect peer
Description

Major New Zealand diagnostic imaging provider offering X-ray, CT, MRI, ultrasound, mammography, and interventional procedures. Directly competes with IDX's Astra Radiology, Trinity MRI, and SRG Radiology in the New Zealand market.

TypeDirect peer
Description

Capitol Health was a direct competitor operating a network of diagnostic imaging clinics across Australia before being acquired by IDX in December 2024. Pre-merger it was a near-clone of IDX with comparable modalities and clinic footprint.

TypeDirect peer
Description

Healius operates the Lumus Imaging network alongside its pathology business, providing diagnostic imaging services across Australia. Directly competes with IDX on hospital contracts, GP referrals, and imaging modalities including MRI, CT, X-ray, and PET.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries21 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Integral Diagnostics

Diagnostic Imaging Servicesintegraldiagnostics.com.au

Integral Diagnostics (ASX: IDX) operates 155 diagnostic imaging clinics across Australia and New Zealand, employing 350+ radiologists to deliver X-ray, CT, MRI, ultrasound, mammography, PET-CT and interventional imaging services to referred patients, hospitals and screening programs.

What Integral Diagnostics does

Integral Diagnostics Limited (ASX: IDX) is an Australian-headquartered, publicly listed diagnostic imaging services provider operating a network of 155 clinics across six Australian states and New Zealand, supported by 350+ radiologists and 3,000+ employees following the December 2024 merger with Capitol Health. The company delivers a full range of medical imaging modalities — X-ray, CT (including dual-source CT), MRI, ultrasound, mammography, PET-CT, nuclear medicine, bone densitometry, dental imaging and interventional procedures — through regional brands such as Capital Radiology, Apex Radiology, Lake Imaging, South Coast Radiology, Radiology Tasmania, and Astra Radiology in New Zealand. Its technology stack combines PACS/RIS for image management with the Aidoc aiOS AI platform (deployed across 185 facilities, processing 600,000+ cases since 2019) for automated critical-pathology flagging, the IDXt home-based teleradiology platform (124 radiologists) for after-hours and overflow reporting, and a Deloitte-led centralized technology modernization initiative.

The business model is primarily fee-for-service diagnostic imaging reimbursed through Australia's Medicare Benefits Schedule, New Zealand's Accident Compensation Corporation, private health insurers, and government screening programs such as the National Lung Cancer Screening Program (NLCSP) launched July 2025. Revenue streams include patient imaging services billed through referrals (the dominant channel), hospital and enterprise contracts for on-site radiology and teleradiology reporting (via IDXt), and emerging consumer-paid services such as Astra's Auckland whole-body wellness scanning. Distribution combines a physical owned-clinic network with B2B hospital contracts and government-program participation (Chest Scan Australia covers 85 NLCSP-eligible sites). Customers are long-tail referred patients and a meaningful but diversified base of public and private hospitals.

In H1 FY2026, the company reported revenue of AUD 393.5 million (up 55.6% following the Capitol merger), operating EBITDA of AUD 81.1 million (up 75.6%) at a 20.6% margin (+230 bps), and net income of AUD 14.0 million, with FY2026 EBITDA margin guidance of 21% and 7.5% organic growth. Net debt-to-EBITDA improved to 2.5x. The company is targeting the second-largest diagnostic imaging position in Australia and is investing in regional expansion (new clinics in Tasmania, Victoria and South Australia), AI capability scaling with Aidoc, and a wholesale technology modernization with Deloitte.

Integral Diagnostics firmographics

Firmographics
Name
Integral Diagnostics
Legal name
Integral Diagnostics Limited
Website
https://integraldiagnostics.com.au
Company type
Public
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Integral Diagnostics (ASX: IDX) operates 155 diagnostic imaging clinics across Australia and New Zealand, employing 350+ radiologists to deliver X-ray, CT, MRI, ultrasound, mammography, PET-CT and interventional imaging services to referred patients, hospitals and screening programs.
Ownership category
akta.pro rank

Integral Diagnostics industry classification

Industry
Product category
Diagnostic Imaging Services
NAICS
Diagnostic Imaging Centers (621512), All Other Outpatient Care Centers (621498)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA)
akta.pro secondary industries
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE)

Keywords

  • Diagnostic imaging services
  • Medical imaging
  • Teleradiology reporting
  • Radiology clinics
  • Healthcare imaging

Where Integral Diagnostics is headquartered

Location

Headquarters

HQ city
North Melbourne
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Integral Diagnostics business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Diagnostic Imaging Services: Fee-for-service medical imaging revenue from X-ray, CT, MRI, ultrasound, mammography, PET-CT, and other imaging modalities. Services are billed through Medicare rebates in Australia and private health insurance, with some services covered under government screening programs like the National Lung Cancer Screening Program.
  2. Hospital Contracts: Contracts with public and private hospitals for radiology services, including after-hours teleradiology through the IDXt platform.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goMedicare-funded diagnostic imaging

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Integral Diagnostics product offering

Product offering

Core offering

Integral Diagnostics operates a network of 155 diagnostic imaging clinics across Australia and New Zealand, providing X-ray, CT, MRI, ultrasound, mammography, PET-CT, nuclear medicine and interventional radiology services. The company also runs the IDXt teleradiology platform delivering overflow and after-hours reporting to hospitals and community practices, and has launched Chest Scan Australia to support the National Lung Cancer Screening Program.

Product overview

Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, operating as a unified platform of 20+ regional brands and 155 clinics. The portfolio includes core teleradiology platform IDXt, regional practices (Apex Radiology, Capital Radiology, Lake Imaging, Radiology Tasmania, South Coast Radiology, Sunshine Coast Radiology), subspecialty centers (Imaging at Olympic Park for musculoskeletal, Astra Radiology for wellness imaging in NZ), and Chest Scan Australia for lung cancer screening. Services span X-ray, CT, MRI, ultrasound, mammography, PET-CT, nuclear medicine, bone densitometry, cardiac imaging, and interventional procedures. The company employs 350+ radiologists across 3,000+ employees, augmented by Aidoc AI technology for automated pathology flagging.

Differentiator

Problem solved

Functional benefit

Brands

  • Chest Scan Australia: Brand developed to support the National Lung Cancer Screening Program, providing easy access to lung cancer screening throughout Australia with 85 eligible sites
  • IDXt

Products and services

  • Diagnostic Imaging Services Core imaging examinations including X-ray, CT, MRI, ultrasound, mammography, PET-CT, nuclear medicine, interventional radiology, dental imaging, and bone densitometry (DEXA) provided to patients referred by GPs or specialists across the IDX clinic network.
  • IDXt Teleradiology Specialist overflow and after-hours teleradiology reporting service for hospitals and community practices, with 124 radiologists (33% growth) providing remote radiology reporting capacity.
  • Chest Scan Australia Brand developed to support the National Lung Cancer Screening Program (NLCSP), providing low-dose CT chest scans and expert subspecialty chest reporting at 85 eligible sites across Australia. Medicare introduced two new lung screening items as part of the NLCSP on 1 July 2025.
  • Astra Radiology Wellness Imaging First-of-its-kind whole-body wellness scanning service in Auckland, New Zealand, in partnership with Well For Life, Autonomy Health, and Novator. Services include Multi-region MRI, CT Coronary Artery and Calcium Score, Lung CT, Prostate MRI, and DEXA Bone Density Scanning for early intervention and preventive healthcare.
  • Cardiac Imaging Services Range of cardiac imaging services including CT Calcium Score screening, CT Coronary Arteries, Echocardiography, and Myocardial Perfusion (MIBI) scans to assist GP or Specialist in diagnosis.
  • Dual Source CT Scanning Premium cardiac CT imaging and advanced imaging applications using Siemens SOMATOM dual source CT technology, providing superior image quality, fast speed, and lowest radiation dose for patients, with the ability to perform cardiac CT at any heart rate.

Quantifiable outcome

  • 600,000+ cases processed by Aidoc AI platform since 2019
  • +3 more outcomes

Companies that use Integral Diagnostics

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Integral Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Integral Diagnostics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • Well For LifeminorStrategic or Co-development Partner · 14 January 2026Astra Radiology partnered with Well For Life, a wellness provider in Auckland, New Zealand, to deliver whole-body wellness scanning services as part of a holistic preventive healthcare offering.
  • Autonomy HealthminorStrategic or Co-development Partner · 14 January 2026Astra Radiology partnered with Autonomy Health, a wellness provider in Auckland, New Zealand, to deliver whole-body wellness scanning services as part of a holistic preventive healthcare offering.
  • NovatorminorStrategic or Co-development Partner · 14 January 2026Astra Radiology partnered with Novator as a wellness provider in Auckland, New Zealand, to deliver whole-body wellness scanning services as part of a holistic preventive healthcare offering.
  • DeloittecoreImplementation/ SI/ Consulting Partner · 17 April 2025Technology modernization initiative implementing a centralized system to improve data integration, automation, and operational flexibility. The initiative aims to address issues of data silos and fragmented systems, enabling better data-driven decision-making.
  • AidoccoreTechnology or Integration · 16 October 2024Expanded AI partnership with Aidoc, a global pioneer in clinical AI solutions. Aidoc's award-winning aiOS platform automatically flags critical pathologies including brain aneurysms, pulmonary embolisms, stroke, and brain bleeds. Since 2019, Aidoc has processed over 600,000 cases across 185 facilities for IDX. The partnership includes trialing new chest CT AI algorithms for the National Lung Cancer Screening Program.

Scale indicators12 records

Recent moves11 records

Expansion highlights6 records

Integral Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • Ramsay Health Care: Australia's largest private hospital operator, with diagnostic imaging embedded in many of its facilities and through Ramsay Connect. Overlaps with IDX on hospital imaging contracts and radiology services within hospitals.
  • Sonic Healthcare: Sonic Healthcare is a global diagnostics powerhouse primarily focused on pathology but also operating imaging services through brands such as SKG Radiology and Queensland X-Ray. It competes with IDX on hospital and specialist contracts and offers broader diagnostics portfolio.

Others

  • Aidoc: Clinical AI platform partner of IDX that automatically flags critical pathologies in medical images. While not a direct competitor, Aidoc is a strategic technology enabler for IDX's AI-powered radiology workflow and a key ecosystem partner.

Direct peers

  • I-MED Radiology Network: Largest diagnostic imaging provider in Australia, operating a network of clinics offering X-ray, CT, MRI, ultrasound, nuclear medicine, and interventional radiology. Directly competes with IDX in metropolitan and regional markets across Australia on referral channels, hospital contracts, and radiologist talent.
  • Queensland X-Ray: Queensland X-Ray operates a network of diagnostic imaging clinics across Queensland, offering a comprehensive range of imaging modalities. Direct regional competitor to IDX's Imaging Queensland, Sunshine Coast Radiology and Central Queensland Radiology brands in the Queensland market.
  • Mercy Radiology: New Zealand-based diagnostic imaging provider with multiple Auckland locations offering MRI, CT, ultrasound, X-ray and women's imaging services. Directly competes with IDX's Auckland-based Astra Radiology in the New Zealand market.
  • Pacific Radiology: Major New Zealand diagnostic imaging provider offering X-ray, CT, MRI, ultrasound, mammography, and interventional procedures. Directly competes with IDX's Astra Radiology, Trinity MRI, and SRG Radiology in the New Zealand market.
  • Capitol Health (merged into IDX): Capitol Health was a direct competitor operating a network of diagnostic imaging clinics across Australia before being acquired by IDX in December 2024. Pre-merger it was a near-clone of IDX with comparable modalities and clinic footprint.
  • Healius (Lumus Imaging): Healius operates the Lumus Imaging network alongside its pathology business, providing diagnostic imaging services across Australia. Directly competes with IDX on hospital contracts, GP referrals, and imaging modalities including MRI, CT, X-ray, and PET.

Emerging players

  • Canopy Healthcare: New Zealand healthcare provider offering diagnostic imaging alongside other specialist services. Operates in NZ where IDX has presence through Astra, Trinity MRI and SRG, representing a smaller-scale regional competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Integral Diagnostics social profiles

Digital presence

Integral Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Integral Diagnostics leadership team

Management profile

Number of profiles

Profiles14 records

Integral Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries21 records

Integral Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Integral Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Integral Diagnostics

What does Integral Diagnostics do?

Integral Diagnostics operates a network of 155 diagnostic imaging clinics across Australia and New Zealand, providing X-ray, CT, MRI, ultrasound, mammography, PET-CT, nuclear medicine and interventional radiology services. The company also runs the IDXt teleradiology platform delivering overflow and after-hours reporting to hospitals and community practices, and has launched Chest Scan Australia to support the National Lung Cancer Screening Program.

Is Integral Diagnostics a public or private company?

Integral Diagnostics is a public company. It is classified as public and is currently operating.

When was Integral Diagnostics founded?

Integral Diagnostics was founded in -1. It employs 1,001 to 5,000 people.

Where is Integral Diagnostics based?

Integral Diagnostics is headquartered in North Melbourne, Australia, in the Oceania region.

How does Integral Diagnostics make money?

Two revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are hospital Contracts.

Who are Integral Diagnostics's main competitors?

Broad incumbents on record are Ramsay Health Care and Sonic Healthcare. Aidoc is listed as an others. Direct peers are I-MED Radiology Network, Queensland X-Ray, Mercy Radiology, Pacific Radiology, Capitol Health (merged into IDX) and Healius (Lumus Imaging). Canopy Healthcare is listed as an emerging player.

Does Integral Diagnostics have an API?

No public API is recorded for Integral Diagnostics.

What industry is Integral Diagnostics in?

Integral Diagnostics's product category is Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound), with a secondary code of HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology). Its NAICS code is 621512 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooIntegral Diagnostics Ltd (ITGDF) (FY 2026) Earnings Call Highlights: Revenue Surges 25. ...Integral Diagnostics reported FY26 revenue of $788.7 million, up 25.6% from $628 million, with operating NPAT of $47.4 million and diluted EPS of $0.126. Operating EBITDA margin rose 80 basis points to 20.9%, leverage fell to 2.3 times EBITDA, and MRI units doubled to 42. A fully franked final dividend of $0.06 per share, a 50% increase, was declared.Investing.comIDX FY26 presentation: 30% EBITDA growth, margin expansion ahead By Investing.comIntegral Diagnostics presented FY26 results on August 25, 2026, showing revenue up 25.6% to AUD $788.7 million and operating EBITDA up 30.3% to $164.8 million, with margins expanding 80 basis points to 20.9%. Shares rose 6.14% to $2.42, and management guided FY27 EBITDA margin above 21.0%. A strategic review of New Zealand operations is underway.Investing.comEarnings call transcript: Integral Diagnostics lifts FY2026 profit, shares rise 6.6% By Investing.comIntegral Diagnostics reported FY2026 results showing revenue up 25.6% to AUD 788.7 million, operating NPAT up 50.1% to AUD 47.4 million and operating free cash flow up 30.7% to AUD 106.4 million. Operating EBITDA margin rose to 20.9% and leverage fell to 2.3 times EBITDA. Shares rose 6.58% to $2.43. Management expects FY2027 EBITDA margin above 21.0%.KalkineMedical Imaging in Focus: What Investors Are Watching Around Integral Diagnostics (ASX:IDX)?Integral Diagnostics (ASX:IDX) shares closed at AUD 2.22 on 12 August 2026, recording no daily price change during a trading session where broader Australian equities and the healthcare sector declined. The company continues to operate diagnostic imaging services, with investors monitoring key factors such as healthcare demand, patient volumes, technology investment, and operational efficiency. This flat performance reflects balanced market activity rather than significant changes in the company's underlying fundamentals.KalkineWhat’s Behind the Market Attention on Integral Diagnostics (ASX:IDX) Today?Integral Diagnostics Limited (ASX:IDX) shares declined by 2.02% to AUD 2.185 on August 7, 2026, amidst a broader downturn in the healthcare sector where the S&P/ASX 200 Health Care index fell 0.73%. The company operates within the diagnostic imaging sector, providing medical imaging services across Australian healthcare markets. The article notes that specific fundamental reasons for the decline were not identified, attributing the movement to general market sentiment and sector pressure.KalkineCould Healthcare Demand Trends Shape Investor Views on Integral Diagnostics (ASX:IDX)?Integral Diagnostics (ASX:IDX) shares declined by 1.35% to AUD 2.19 on August 6, 2026, during a session where the broader Australian healthcare sector and stock market recorded gains. The article outlines that investor attention for diagnostic imaging companies focuses on long-term factors such as healthcare demand, patient volumes, operational efficiency, and technology investment rather than daily price fluctuations. It emphasizes that while demographic trends support ongoing demand for medical imaging services, short-term share movements reflect market sentiment rather than immediate changes in company fundamentals.AInvestIntegral Diagnostics Limited - start for new managing director and chief executive officerIntegral Diagnostics Limited (ASX:IDX) has announced the commencement date for its new Managing Director and Chief Executive Officer, as previously disclosed by the company. The leadership change is part of the company's ongoing strategic direction and governance structure, with the new CEO assuming responsibilities at the company's East Melbourne headquarters. No further details regarding the transition process or the individual's prior experience have been disclosed in the provided materials.Kalkine MediaWhy Integral Diagnostics Imaging Business Sustains Growth Trajectory Is in Focus (ASX:IDX)?Integral Diagnostics is maintaining its growth trajectory in the imaging business, driven by demographic trends such as an aging population that increases demand for diagnostic services. The company's operational focus remains on execution, market share, and balance sheet flexibility to ensure sustainable performance within the Australian healthcare sector. This strategic discipline is being closely monitored by investors as a key indicator of long-term business quality.KalkineIntegral Diagnostics Ltd (ASX:IDX) advances with healthcare equitiesIntegral Diagnostics Ltd (ASX:IDX) shares rose 0.96% to $2.10 on 29 July 2026, tracking a broader 3.77% advance in the S&P/ASX 200 Health Care Index. The positive sector momentum coincided with constructive economic data showing easing inflation pressures in Australia. The article notes that while daily price movements reflect investor sentiment, they do not necessarily indicate changes in the company's underlying business fundamentals.KalkineIntegral Diagnostics Confirms FY26 Results Release and Investor Conference Call for August 2026Integral Diagnostics Limited (ASX: IDX) has announced it will release its full-year FY26 financial results on the morning of Tuesday, 25 August 2026, immediately followed by an investor conference call at 11:00am AEST. The company, a leading provider of medical imaging services across Australia and New Zealand, has provided registration and dial-in details to enable investors to participate and hear directly from management about the company's performance and strategic direction. This scheduled disclosure represents routine corporate calendar management and investor relations activity standard for ASX-listed companies.